Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 12, 2010, Pages 1713-1718

  Nazari, Hossein ^a   Modarres, Mehdi ^a   Parvaresh, Mohammad Mehdi ^a   Ghasemi Falavarjani, Khalil ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intravitreal bevacizumab injection; Retinal hemorrhage; Retinopathy of prematurity; Vitreous hemorrhage

Indexed keywords

BEVACIZUMAB;

ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; RETINA HEMORRHAGE; RETROLENTAL FIBROPLASIA; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTRAVITREAL INJECTIONS; LASER COAGULATION; MALE; PROSPECTIVE STUDIES; RETINAL HEMORRHAGE; RETINOPATHY OF PREMATURITY; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS HEMORRHAGE;

EID: 78549266120     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1430-x     Document Type: Article

References (32)

1. Early Treatment for Retinopathy of Prematurity Cooperative Group 2003 Revised indications for the treatment of retinopathy of prematurity. Results of The Early Treatment for Retinopathy of Prematurity Randomized Trial Arch Ophthalmol 121 1684 1696 1:STN:280:DC%2BD3srotFKmsA%3D%3D 10.1001/archopht.121. 12.1684 14662586 (Pubitemid 37517433)
2. N Azuma K Ishikawa Y Hama M Hiraoka Y Suzuki S Nishina 2006 Early vitreous surgery for aggressive posterior retinopathy of prematurity Am J Ophthalmol 142 636 643 10.1016/j.ajo.2006.05.048 17011857 (Pubitemid 44442071)
3. T Micelli Ferrari C Furino VV Lorusso R Dammacco G Sborgia L Sborgia G Besozzi 2007 Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance Eur J Ophthalmol 17 785 789 1:STN:280:DC%2BD2sngvVGhuw%3D%3D 17932856
4. KA Hutcheson ATQ Nquyen MW Reslan NJ Ellish SM Steidl 2003 Vitreous hemorrhage in patients with high-risk retinopathy of prematurity Am J Ophthalmol 136 258 263 10.1016/S0002-9394(03)00190-9 12888047 (Pubitemid 36904072)
5. MJ Kim S Kim YS Yu 2008 The risk for retinal detachment associated with hemorrhages pre and postlaser treatment in retinopathy of prematurity Retina 28 1451 1457 10.1097/IAE.0b013e31817f2f15 19009681
6. A Vinekar MT Trese A Capone Jr Photographic Screening for Retinopathy of Prematurity (PHOTO-ROP) Cooperative Group 2008 Evolution of Retinal Detachment in Posterior Retinopathy of Prematurity: Impact on Treatment Approach Am J Ophthalmol 145 548 555 10.1016/j.ajo.2007.10.027 18207120
7. K Sonmez KA Drenser A Capone Jr MT Trese 2008 Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity Ophthalmology 115 1065 1070 10.1016/j.ophtha.2007.08. 050 18031819 (Pubitemid 351749696)
8. K Lashkari T Hirose J Yazdany JW McMeel A Kazlauskas N Rahimi 2000 Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity Am J Pathol 156 1337 1344 1:CAS:528:DC%2BD3cXjtV2itro%3D 10751359
9. RM Rich PJ Rosenfeld CA Puliafito SR Dubovy JL Davis HW Flynn Jr S Gonzalez WJ Feuer RC Lin GA Lalwani JK Nguyen G Kumar 2006 Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Retina 26 495 511 10.1097/01.iae.0000225766.75009.3a 16770255 (Pubitemid 44620390)
10. SA Pai R Shetty PB Vijayan G Venkatasubramaniam NK Yadav BK Shetty RB Babu KM Narayana 2007 Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion Am J Ophthalmol 143 601 606 1:CAS:528:DC%2BD2sXjsVWitbw%3D 10.1016/j.ajo.2006. 12.037 17306753 (Pubitemid 46452523)
11. RF Spaide YL Fisher 2006 Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage Retina 26 275 278 10.1097/00006982-200603000-00004 16508426 (Pubitemid 44318179)
12. HA Mintz-Hittner RR Kuffel 2008 Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II Retina 28 831 838 10.1097/IAE.0b013e318177f934 18536599
13. H Quiroz-Mercado MA Martinez-Castellanos ML Hermamdez-Rojas N Salazar-Teran RV Chan 2008 Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity Retina 28 S19 S25 10.1097/IAE.0b013e318159ec6b 18317339 (Pubitemid 351644419)
14. EJ Chung JH Kim HS Ahn HJ Koh 2007 Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity Graefes Arch Clin Exp Ophthalmol 245 1727 1730 1:CAS:528: DC%2BD2sXhtV2msbzN 10.1007/s00417-007-0661-y 17690897 (Pubitemid 47491565)
15. GA Lalwani AM Berrocal TG Murray M Buch S Cardone D Hess RA Johnson CA Puliafito 2008 Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity Retina 28 S13 S18 10.1097/IAE.0b013e3181644ad2 18317338 (Pubitemid 351644418)
16. PK Shah V Narendran KA Tawansy A Raghuram K Narendran 2007 Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity Indian J Ophthalmol 55 75 76 10.4103/0301-4738.29505 17189897
17. S Kusaka C Shima K Wada H Arahori H Shimojyo T Sato T Fujikado 2008 Efficacy of intravitreal injection of Bevacizumab for severe retinopathy of prematurity: A pilot study Br J Ophthalmol 92 1450 1455 1:STN:280: DC%2BD1cnosVGquw%3D%3D 10.1136/bjo.2008.140657 18621796
18. JA Micieli M Surkont AF Smith 2009 A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity Am J Ophthalmol 148 536 543 1:CAS:528:DC%2BD1MXhtFOqu77J 10.1016/j.ajo.2009.05.031 19660736
19. Q Schwarz C Gu H Fujisawa K Sabelko M Gertsenstein A Nagy M Taniguchi AL Kolodkin DD Ginty DT Shima C Ruhrberg 2004 Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve Genes Dev 18 2822 2834 1:CAS:528: DC%2BD2cXhtVCjt7%2FL 10.1101/gad.322904 15545635 (Pubitemid 39507774)
20. K Nishijima YS Ng L Zhong J Bradley W Schubert N Jo J Akita SJ Samuelsson GS Robinson AP Adamis DT Shima 2007 Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury Am J Pathol 171 53 67 1:CAS:528: DC%2BD2sXosValsrs%3D 10.2353/ajpath.2007.061237 17591953 (Pubitemid 47339226)
21. L Kong HA Mintz-Hittner RL Penland FL Kretzer P Chévez-Barrios 2008 Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study Arch Ophthalmol 126 1161 1163 10.1001/archophthalmol.2008.1 18695118
22. HA Mintz-Hittner LM Best 2009 Antivascular endothelial growth factor for retinopathy of prematurity Curr Opin Pediatr 21 182 187 10.1097/MOP. 0b013e32832925f9 19300261
23. An International Committee for Classification of Retinopathy of Prematurity 2005 The International Classification of Retinopathy of Prematurity Arch Ophthalmol 123 991 999 10.1001/archopht.123.7.991 (Pubitemid 41057999)
24. MM Parvaresh M Modarres KG Falavarjani K Sadeghi P Hammami 2009 Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity J AAPOS 13 535 538 10.1016/j.jaapos.2009.09.018 20006811
25. J Chen LE Smith 2007 Retinopathy of prematurity Angiogenesis 10 133 140 10.1007/s10456-007-9066-0 17332988 (Pubitemid 46440629)
26. C Löfqvist E Andersson J Sigurdsson E Engström AL Hård A Niklasson LE Smith A Hellström 2006 Longitudinal postnatal weight and insulin-like growth factor 1 measurements in the prediction of retinopathy of prematurity Arch Opthalmol 124 1711 1718 10.1001/archopht.124.12.1711 (Pubitemid 44913194)
27. A Kychenthal P Dorta X Katz 2006 Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes Retina 26 S11 S15 10.1097/01.iae.0000244285.79004.e6 16946670 (Pubitemid 44341906)
28. DK Coats AM Miller MA Hussein KM McCreery E Holz EA Paysse 2005 Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment Am J Ophthalmol. 140 214 222 10.1016/j.ajo.2004.12.106 16086945 (Pubitemid 41125799)
29. DK Coats 2005 Retinopathy of prematurity involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical intervention Trans Am Ophthalmol Soc 103 281 312 17057808
30. JF Arevalo M Maia HW Flynn Jr M Saravia RL Avery L Wu M Eid Farah DJ Pieramici MH Berrocal JG Sanchez 2007 Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy Br J Ophthalmol 92 213 216 10.1136/bjo.2007.127142 17965108
31. S Honda H Hirabayashi Y Tsukahara A Negi 2008 Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity Graefes Arch Clin Exp Ophthalmol 246 1061 1063 1:CAS:528:DC%2BD1cXmtlygs70%3D 10.1007/s00417-008-0786-7 18320201
32. RL Avery 2009 Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern J AAPOS 13 329 331 10.1016/j.jaapos.2009.06.003 19683181